ORIGINAL FILING ON SCHEDULE 13D

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

July 3, 2003

Accession Number

0000950123-03-007907

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →